[PDF][PDF] Post-myocardial Infarction heart failure: a review on management of drug therapies

G Swaroop - Cureus, 2022 - cureus.com
After myocardial infarction (MI), patients are at a greater risk of heart failure. Post-MI patients
with left ventricular systolic dysfunction have a higher risk of mortality or morbidity. Strong …

Established and emerging pharmacological therapies for post-myocardial infarction patients with heart failure: a review of the evidence

L De Luca - Cardiovascular Drugs and Therapy, 2020 - Springer
After an episode of myocardial infarction (MI), patients remain at risk for recurrent ischemic
events, heart failure (HF), and sudden death. Post-MI patients with left ventricular systolic …

Pharmacologic therapies across the continuum of left ventricular dysfunction

WT Abraham, BH Greenberg, CW Yancy - The American journal of …, 2008 - Elsevier
Neurohormonal activation and increased sympathetic stimulation are among the factors that
have been linked to the development and progression of left ventricular dysfunction (LVD) …

Therapies to prevent heart failure post-myocardial infarction

KL Thomas, EJ Velazquez - Current Heart Failure Reports, 2005 - Springer
Heart failure (HF) is a common complication of myocardial infarction (MI) that carries a poor
prognosis when present. HF and/or left ventricular systolic dysfunction (LVSD) occur in …

Management of post-myocardial infarction patients with left ventricular systolic dysfunction

M Gheorghiade, GC Fonarow - The American journal of medicine, 2007 - Elsevier
After a myocardial infarction (MI), patients are at risk for reinfarction, heart failure (HF), and
sudden death. This risk is much higher in patients with left ventricular systolic dysfunction …

Managing the post-myocardial infarction patient with asymptomatic left ventricular dysfunction

GJ Philippides - Cardiology, 2006 - karger.com
The percentage of post-myocardial infarction (MI) patients with asymptomatic left ventricular
dysfunction (ALVD) is now estimated at 10%, and that number is expected to grow as …

Heart failure after myocardial infarction: clinical implications and treatment

MF Minicucci, PS Azevedo, BF Polegato… - Clinical …, 2011 - Wiley Online Library
Heart failure is a frequent complication of myocardial infarction. Several factors, such as
recurrent myocardial ischemia, infarct size, ventricular remodeling, stunned myocardium …

Medical therapy for heart failure caused by ischemic heart disease

IY Elgendy, D Mahtta, CJ Pepine - Circulation research, 2019 - Am Heart Assoc
Patients with heart failure (HF) syndromes have been categorized as those with reduced
ejection fraction (EF) or preserved EF (HFpEF), and ischemia plays a key role in both types …

Role of neurohormonal modulators in heart failure with relatively preserved systolic function

JA Rapp, M Gheorghiade - Cardiology clinics, 2008 - Elsevier
Cardiovascular disease remains the leading cause of mortality in the developed world. It is
estimated that 5 million Americans suffer from heart failure (HF), and roughly 550,000 new …

Mechanism of heart failure after myocardial infarction

H Jiang, T Fang, Z Cheng - Journal of International Medical …, 2023 - journals.sagepub.com
Despite the widespread use of early revascularization and drugs to regulate the
neuroendocrine system, the impact of such measures on alleviating the development of …